Tumor-draining lymph node (TDLN) cells were collected after 48 h of NLGP treatment and found higher per-cell MHC-I expression along with increased CD80 and CCR7 in comparison to control (Figures 5A1,A2, also in contralateral lymph node and tumor; Figure S5AA). Here, CD80 is linked to neoplasm.